abstract |
Compounds of the formula I: n nor pharmaceutically acceptable salts, solvates or prodrugs thereof,n nwherein m, k, B, R 1 , R 2 and R 3 are those defined herein, and compositions comprising the same. Also provided are methods for preparing compounds of formula I and using the same in treating p38 mediated disorders in a patient. |